TuDiabetes - A Community for People Touched by Diabetes

Update, from a press release issued by the International Diabetes Federation (June 29):

Statement from the International Diabetes Federation Related to Studies Published in Diabetelogia Suggesting Possible Link Between Insulin Glargine and Cancer

The International Diabetes Federation (IDF) today called for urgent assessment and responses from regulatory authorities into a possible link between the use of insulin glargine (an insulin analogue) and increased risk of cancer based on findings published on 26 June, 2009 in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD).

The online data published in Diabetelogia is based on four studies relating to a possible link between a long-acting insulin analogue, insulin glargine and cancer. According to EASD, the findings are based on evidence from studies in Germany, Sweden, Scotland and the United Kingdom. The studies however, are not conclusive.

The International Diabetes Federation understands the concern about the Diabetelogia study findings but urges the diabetes community to wait for the current scientific information to be released and calls for urgent further scientific studies to be undertaken in other countries.

The International Diabetes Federation stresses that it is important that people needing insulin do not stop taking the drug. IDF cautioned that people with diabetes should see their doctor for advice before considering any change to their treatment.


Original post, June 26:
"Our information is that indeed a study is likely to be published soon raising the possibility of a link between Lantus use and a certain cancer type," Sanford Bernstein analyst Tim Anderson said in a research note.

More details:
http://www.reuters.com/article/euPrivateEquityNews/idUSTRE55P2PM200...

Tags: aventis, lantus, sanofi

Share

Replies are closed for this discussion.

Replies to This Discussion

The bigger question is should long-acting analogues be the default treatment over a lifetime, or should it be used only when proven treatments fail to achieve adequate glycemic control safely? See the journal article prompting these questions at http://www.diabetologia-journal.org/cancer.html.
It is VERY, VERY, VERY important for everyone to consider this:
People needing insulin do not stop taking their insulin. You should see your doctor for advice before considering any change to your treatment.

For more comments on this, read Amy Tenderich's post about it:
http://www.diabetesmine.com/2009/06/does-lantus-cause-cancer.html
Closing this topic (because it is now redundant) and linking to another existing (and more active) topic:
http://tudiabetes.com/forum/topics/lantus-verdict-may-cause

RSS

© 2009   Created by Diabetes Hands Foundation, P.O. Box 9421, Berkeley, CA 94709.
Diabetes Hands Foundation (DHF) is a 501(c)(3) nonprofit. Donations to DHF are eligible to be deducted.

Disclaimer
The contents of TuDiabetes is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition, including without limitation diabetes. Never disregard professional medical advice or delay in seeking it because of something you have read on TuDiabetes.

If you think you may have a medical emergency, call your doctor or 911 immediately. The Diabetes Hands Foundation does not endorse any specific tests, physicians, products, services, procedures, opinions, or other information that are advertised or mentioned on the web site.


TuDiabetes®, TuDiabetes.org®, Word in Your Hand™, Drawing Diabetes™, Diabetes Supplies Art™ and No-Sugar Added Poetry™ are trademarks or registered trademarks of the Diabetes Hands Foundation.

Badges  |  Contact Us  |  Privacy  |  Terms of Service